K. Hiramatsu et al., GENERATION OF KILLER ACTIVITY BY INTERLEUKIN-12 OF MONONUCLEAR-CELLS IN MALIGNANT PLEURAL EFFUSIONS DUE TO LUNG-CANCER, Cancer immunology and immunotherapy, 46(1), 1998, pp. 1-6
In the present study, we examined the ability of interleukin (IL)-12 t
o generate an antitumor effect in the tumor-growing site. Mononuclear
cells (MNC) were obtained from 12 malignant pleural effusions due to l
ung cancer in the tumor-growing site. Non-major-histocompatibility-com
plex-restricted killer activity, examined by 4-h Cr-51 release assay a
gainst Daudi lymphoma cells as well as various lung cancer cell lines
(H69 and PC-9), and in vitro production of interferon gamma (IFN gamma
), measured by enzyme immunoassay, were investigated as mediators of a
ntitumor effects of host cells activated by IL-12. IL-12 induced kille
r activity of MNC in pleural effusions (pleural MNC) dose-dependently.
Moreover, pleural MNC produced a signficant amount of IFN gamma in re
sponse to IL-12. The killer activities of IL-12-activated blood MNC we
re higher than those of pleural MNC. The supernatants of pleural effus
ions of these untreated patients suppressed killer induction by IL-12
of blood MNC of healthy volunteers. These observations suggest that MN
C present at the site of growing tumors may act as effector cells agai
nst lung cancer in the presence of IL-12.